DSIP and sleep measurements: why a difference is not always meaningful
Study design: Humans; double-blind crossover study
The research question
More time in a particular sleep stage may be interesting. However, it does not automatically mean that someone sleeps better. A short DSIP study helps clarify that distinction.
What was found?
The researchers recorded sleep with DSIP and placebo. There were changes in, among other things, NREM sleep and stage 2 sleep. For several other measures, the differences were not significant. In addition, some group differences were already present at baseline. The authors assessed the clinical significance of the improvement as slight.
What does this evidence mean?
A baseline difference can make it more difficult to interpret a later difference. Therefore, a blog post about DSIP should look beyond an isolated positive measurement. This study does not provide strong evidence for a relevant treatment for insomnia.
Primary source
Research information, not medical advice. The study described does not establish a safe use for an investigational product. Image: AI illustration, not a participant or a photograph from the study.
Related research products
View product specifications and available batch documentation. The studies discussed were not conducted with Peptidera products and do not prove the efficacy of our products. For laboratory research only; not for human or animal consumption.